HOME >> BIOLOGY >> NEWS
Jefferson Researchers Provide Leads To Potential Parkinson's Treatment

A Natural Substance In The Cell Membrane May Either Protect Or Stimulate Brain Cell Activity

A naturally occurring substance in the cell's membrane may improve symptoms in Parkinson's disease patients and perhaps even help slow down the progression of Parkinson's, according to studies by researchers at Jefferson Medical College of Thomas Jefferson University in Philadelphia.

Jay S. Schneider, Ph.D., professor of pathology, cell biology and anatomy and neurology and his co-workers compared a drug, GM1 ganglioside, with a placebo in 45 patients with Parkinson's disease receiving a 16-week course of treatment.

"At the end of the study, test scores in the Unified Parkinson's Disease Rating Scale, which is a standard scale to measure motor abilities, showed a significant difference between those who received the drug and those who did not," says Dr. Schneider. He and his colleagues at Jefferson report their findings in the June issue of the journal Neurology.

The study was a double-blind trial, with neither the researchers nor the patients knowing who receives the drug. GM1 ganglioside is a normal part of the cell membrane that plays an important role in cell growth, development, signal transduction and repair after injury.

According to Dr. Schneider, many of the patients' symptoms, such as rigidity and slow movement, improved during participation in the trial. Patients also reported that they were able to function better in performing daily living activities, such as dressing and handling eating utensils. "Overall, every patient receiving GM1 improved to some degree," he says. "They had less stiffness, less bradykinesia or slowness of movement, and better manual dexterity and motor coordination."

While some participants in the placebo group also slightly improved, the condition of the majority of those who did not receive the drug remained unchanged.

Dr. Schneider and his gr
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-6300
Thomas Jefferson University
22-Jun-1998


Page: 1 2 3

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2019)... ... , ... Join Julie Peacock, Vice President of Product Marketing ... 19, 2019 at 1pm EDT where she will demonstrate how role-based data solutions ... research organizations (CROs) can improve collaboration, auditing, document tracking and reporting. , Using ...
(Date:5/23/2019)... ... May 23, 2019 , ... Federal Publications Seminars, the leading provider ... to announce the release of FPSOnline 2.0, an updated version of its FPSOnline ... conferences , La Jolla Government Contracts Week, were given a “sneak peek” of FPSOnline ...
(Date:5/21/2019)... ... May 21, 2019 , ... Experiential tourism, a trend encompassing ... over the last several years. And according to a recent report by Skift, ... In fact, more and more travelers are wanting their journeys to be authentic ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, ... the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production ... and commercialization rights to a full spectrum of botulinum neurotoxins, as well as ...
(Date:5/22/2019)... NEW YORK (PRWEB) , ... May 22, 2019 , ... ... it has closed a $8 million Series A funding round co-led by Astanor ... State’s Empire State Development Fund and iSelect Fund . The company ...
(Date:5/15/2019)... ... , ... Milton Hershey School® has named William Charles Ballough Harding ’78 the ... where he is changing lives by creating solutions to global healthcare challenges through the ... of our founders – Milton and Catherine Hershey – who always hoped for Milton ...
(Date:5/14/2019)... ... May 13, 2019 , ... Leak Detection Associates (LDA), the ... Biotechnology, Medical Device and Food Packaging Industries’ is excited to announce the go-live ... LDA’s ability to communicate directly with the marketplace; serving as a destination to ...
Breaking Biology Technology:
Cached News: